Navigation Links
Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting

in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder APA Poster# NR750 DAYTRANA (methylphenidate transdermal system): May 23, 2007; 12:00 p.m. PDT (3:00 p.m. EDT) Efficacy and Safety of MTS in Male and Female Pediatric Subjects with ADHD APA Poster# NR665 May 23, 2007; 12:00 p.m. PDT (3:00 p.m. EDT) 12-Month Efficacy and Tolerability of MTS in Children with ADHD APA Poster# NR664 ADDERALL XR (mixed salts of a single-entity amphetamine product): May 23, 2007; 12:00 p.m. PDT (3:00 p.m. EDT) Long-Term Cardiovascular Safety of Mixed Amphetamine Salts Extended Release in Adolescents with ADHD APA Poster# NR652 SPD465 (triple-bead mixed amphetamine salts): May 21, 2007; 11:00 a.m. PDT (2:00 p.m. EDT) Extended Duration of Action of SPD465, a 16-Hour Mixed Amphetamine Salts Formulation, in the Treatment of Adults with ADHD Oral Presentation SPD503 (guanfacine HCl extended release): May 23, 2007; 12:00 p.m. PDT (3:00 p.m. EDT) A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents with Attention- Deficit/Hyperactivity Disorder APA Poster# NR659 May 23, 2007; 12:00 p.m. PDT (3:00 p.m. EDT) Long-Term, Open-Label Study of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder APA Poster# NR658

About VYVANSE and ADDERALL XR

VYVANSE or ADDERALL XR should not be taken by patients who have advanced arteriosclerosis; symptomatic cardiovascular disease; moderate to severe hypertension; hyperthyroidism; known hypersensitivity or idiosyncrasy to sympathomimetic amines; agitated states; glaucoma; a history of drug abuse; or during or within 14 days after treatment with monoamine oxidase inhibitors (MAOIs).

Sudden death has been reported in association with CNS stimulant treatment
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:2/27/2015)... MISSISSAUGA, ON , Feb. 27, 2015 /CNW/ - Covalon ... advanced medical technologies company, today announced financial results for ... For the three months ended December 31, 2014, ... for the quarter was $229,820 or $0.02 per share.  ... Pedlar , said "I am very pleased with the ...
(Date:2/27/2015)... , Feb. 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), ... announced today that it acquired Bionik Laboratories, Inc., a ... completed the sale to qualified accredited investors of units ... gross proceeds of approximately $6.2 million. Shares of the ... the OTC Markets under the symbol "DWTPD" until FINRA,s ...
(Date:2/26/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... the t:slim® and t:flex™ Insulin Pumps, today announced the ... of its common stock at a price to the ... Tandem from this offering are expected to be $56.3 ... estimated offering expenses payable by Tandem. All of the ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... China-based pharmaceutical and biotechnology research and development outsourcing ... main Chinese subsidiary, Shanghai ChemPartner Co. Ltd. ("ChemPartner"), ... Inc.,s ("Charles River") Shanghai research facility. ...
... ® Labeling, part of Newell Rubbermaid,s Technology global ... scanner designed to streamline workflow and assist healthcare facilities ... records (EHR). DYMO CardScan Image Capture ... with EHR or practice management software systems. It delivers ...
Cached Medicine Technology:ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 2DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing 2DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing 3
(Date:2/28/2015)... 28, 2015 In a recent episode ... of Game Change Athlete Development Services and ... the benefits of athlete development and player engagement during ... unique challenges that athletes face and how off-field activities ... , Fletcher became involved in athlete development issues while ...
(Date:2/28/2015)... The Heart Fit Clinic started doing External ... machine. The Heart Fit Clinic is also selling the ... model. The goal is to scale the business to ... buy External Counterpulsation machines can be difficult ... this process and achieve the desired results. , ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Mew and ... announced that they now provide business consulting services in ... as corporate tax planning and succession planning. Company finances ... to experienced professionals. On top of this, complex Canadian ... handle corporate accounting. As a result, Mew and Company ...
(Date:2/28/2015)... CA (PRWEB) February 28, 2015 A ... a promising new gene therapy procedure for the treatment ... blindness in patients. Authored by Dr. Robert ... and published in the Lancet Medical Journal on January ... from choroideremia, a rare genetic disorder that mostly affects ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will be on ... Show, an annual, premier sustainable building event in Tokyo, ... manufacturers of the latest building products, services and technology. ... manufactured by Pioneer Millworks from their Oregon and New ... hotels, retailers, and corporate offices. Nichibi Global , ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2
... dermatologist, Dr. William F. Groff, at La Jolla Cosmetic Surgery Centre, is ... pearly penile papules treatment . , ... La Jolla, CA (Vocus) ... problems, pearly penile papules do affect a man’s psychological well-being. ...
... develop breast cancer during their pregnancy, or who are ... difference in rates of local recurrence, distant metastases and ... disease, according to researchers at The University of Texas ... largest single-institution study to look at pregnant breast cancer ...
... A new study demonstrates that a chemical mediator in ... a key role in maintaining the balance between the ... mediator, which acts on cells that degrade bone, may ... preventions for bone-degenerating diseases such as osteoporosis and rheumatoid ...
... WASHINGTON, Feb. 7 As the military deals with ... of Veterans Affairs Eric K. Shinseki reminded Veterans and ... has an extensive array of services to help Veterans ... take advantage of our suicide-prevention program," said Shinseki. "Help ...
... women who got injections report reduced pain and ... first evidence that gene therapy can ease symptoms in ... American and German researchers. , The study included ... interleukin-1 receptor antagonist (IL-1Ra) gene into the women,s affected ...
... PRINCETON, N.J., Feb. 6 Covance Inc. (NYSE: ... 2009 UBS Global Healthcare Conference on Monday, February 9, 2009 ... webcast of the presentation at www.covance.com . In ... on 10 minutes early. , Covance, with headquarters in Princeton, ...
Cached Medicine News:Health News:Pearly Penile Papule Patients Can Successfully Be Treated with Targeted CO2 Technology at La Jolla Cosmetic Surgery Centre 2Health News:Pearly Penile Papule Patients Can Successfully Be Treated with Targeted CO2 Technology at La Jolla Cosmetic Surgery Centre 3Health News:Study finds pregnancy has no impact on breast cancer survival, delays treatment, diagnosis 2Health News:Study finds pregnancy has no impact on breast cancer survival, delays treatment, diagnosis 3Health News:Scientists discover key factor in controlling the breakdown of bone 2Health News:Scientists discover key factor in controlling the breakdown of bone 3Health News:VA Suicide Prevention Hotline Credited with 2,600 'Saves' 2Health News:Gene Therapy May Ease Rheumatoid Arthritis 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: